XOMA Secures Federal Contract to Expand Its Next-Generation Human Botulism Antitoxin Portfolio Oct 03, 2011 8:00am EDT
XOMA Announces Presentation and Webcast at Wedbush Securities 2011 Life Sciences Conference Aug 10, 2011 4:04pm EDT
XOMA to Announce Second Quarter 2011 Financial Results and Host Webcast Conference Call on August 4 Jul 28, 2011 8:00am EDT
XOMA Announces Phase 2a Six-Month Top Line Trial Results Support Safety and Biological Activity Jun 08, 2011 4:15pm EDT
XOMA Announces Presentation and Webcast at Jefferies 2011 Global Healthcare Conference Jun 03, 2011 8:00am EDT
XOMA 3AB, a Novel Triple-Antibody Anti-Botulinum Neurotoxin Product, Enters Phase 1 Clinical Testing May 03, 2011 8:46am EDT